Artefenomel: a promising new antimalarial drug (Q46485558)

22 December 2017

title

Artefenomel: a promising new antimalarial drug (English)

1 reference

22 December 2017

0 references

1

Philip J Rosenthal

1 reference

22 December 2017

publication date

1 October 2015

1 reference

22 December 2017

Lancet Infectious Diseases

published in

1 reference

22 December 2017

volume

16

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

6-8

1 reference

22 December 2017

Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900343-6

7 January 2021

Spread of artemisinin resistance in Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900343-6

7 January 2021

The interplay between drug resistance and fitness in malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900343-6

7 January 2021

Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900343-6

7 January 2021

Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900343-6

7 January 2021

High-level semi-synthetic production of the potent antimalarial artemisinin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900343-6

7 January 2021

Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900343-6

7 January 2021

Comparative Antimalarial Activities and ADME Profiles of Ozonides (1,2,4-trioxolanes) OZ277, OZ439, and Their 1,2-Dioxolane, 1,2,4-Trioxane, and 1,2,4,5-Tetraoxane Isosteres

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900343-6

7 January 2021

First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900343-6

7 January 2021

Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900343-6

7 January 2021

Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900343-6

7 January 2021

The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900343-6

7 January 2021

10.1016/S1473-3099(15)00343-6

Identifiers

DOI

1 reference

22 December 2017

release_z7mbihj6yvcx3cbf4azb4cudye

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z7mbihj6yvcx3cbf4azb4cudye

24 November 2022

mapped directly with Wikidata item

1 reference

22 December 2017